ARCHIVES

Paul Marks To Chair Search Committee For NCI Director

This article is from The Cancer Letter archive.

Vol. 21 No. 03 | January 20, 1995

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets PFS Primary Endpoint

June 29, 2012

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

October 13, 2006

Clinical Trials Approved By NCI

January 30, 2004

Fewer Side Effects With IMRT Than Traditional Radiation

August 31, 2007

Schmidt’s Advice To Upton: Take A Look At grants Vs. Contracts, Carcinogenesis, Cancer Control

July 1, 1977

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979